SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Roy E. Strowd, Mackenzie C. Cervenka, Bobbie J. Henry, Eric H. Kossoff, Adam L. Hartman, Jaishri O. Blakeley, Glycemic modulation in neuro-oncology: experience and future directions using a modified Atkins diet for high-grade brain tumors, Neuro-Oncology Practice, 2015, 2, 3, 127

    CrossRef

  2. 2
    Thomas N. Seyfried, Roberto Flores, Angela M. Poff, Dominic P. D’Agostino, Purna Mukherjee, Metabolic therapy: A new paradigm for managing malignant brain cancer, Cancer Letters, 2015, 356, 2, 289

    CrossRef

  3. 3
    Roy E. Strowd, Stuart A. Grossman, The Role of Glucose Modulation and Dietary Supplementation in Patients With Central Nervous System Tumors, Current Treatment Options in Oncology, 2015, 16, 8

    CrossRef

  4. 4
    Kenneth Schwartz, Howard T Chang, Michele Nikolai, Joseph Pernicone, Sherman Rhee, Karl Olson, Peter C Kurniali, Norman G Hord, Mary Noel, Treatment of glioma patients with ketogenic diets: report of two cases treated with an IRB-approved energy-restricted ketogenic diet protocol and review of the literature, Cancer & Metabolism, 2015, 3, 1

    CrossRef

  5. 5
    Eric C. Woolf, Adrienne C. Scheck, Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease, 2015,

    CrossRef

  6. 6
    Howard T Chang, Lawrence Olson, Kenneth A Schwartz, Ketolytic and glycolytic enzymatic expression profiles in malignant gliomas: implication for ketogenic diet therapy, Nutrition & Metabolism, 2013, 10, 1, 47

    CrossRef

  7. 7
    Thomas N. Seyfried, Jeremy Marsh, Laura M. Shelton, Leanne C. Huysentruyt, Purna Mukherjee, Is the restricted ketogenic diet a viable alternative to the standard of care for managing malignant brain cancer?, Epilepsy Research, 2012, 100, 3, 310

    CrossRef

  8. 8
    Gabriele D Maurer, Daniel P Brucker, Oliver Bähr, Patrick N Harter, Elke Hattingen, Stefan Walenta, Wolfgang Mueller-Klieser, Joachim P Steinbach, Johannes Rieger, Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy, BMC Cancer, 2011, 11, 1, 315

    CrossRef

  9. 9
    Thomas N. Seyfried, Michael A. Kiebish, Jeremy Marsh, Laura M. Shelton, Leanne C. Huysentruyt, Purna Mukherjee, Metabolic management of brain cancer, Biochimica et Biophysica Acta (BBA) - Bioenergetics, 2011, 1807, 6, 577

    CrossRef

  10. 10
    Stephen J. Ralph, Sara Rodríguez-Enríquez, Jiri Neuzil, Rafael Moreno-Sánchez, Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger, Molecular Aspects of Medicine, 2010, 31, 1, 29

    CrossRef

  11. 11
    Robert Skinner, Angelica Trujillo, Xiaojie Ma, Elizabeth A. Beierle, Ketone bodies inhibit the viability of human neuroblastoma cells, Journal of Pediatric Surgery, 2009, 44, 1, 212

    CrossRef

  12. 12
    Amanda E. Greene, Mariana T. Todorova, Thomas N. Seyfried, Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies, Journal of Neurochemistry, 2003, 86, 3
  13. 13
    L C Nebeling, F Miraldi, S B Shurin, E Lerner, Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports., Journal of the American College of Nutrition, 1995, 14, 2, 202

    CrossRef

  14. 14
    T. Chechik, L.M. Roeder, J.T. Tildon, S.E. Poduslo, Ketone body enzyme activities in purified neurons, astrocytes and oligodendroglia, Neurochemistry International, 1987, 10, 1, 95

    CrossRef

  15. 15
    Metabolic Management of Cancer,